Foss FM, Kim YH, Prince HM, Akilov OE, et al. Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation
of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell
Lymphoma. J Clin Oncol 2024 Dec 19:JCO2401549. doi: 10.1200/JCO-24-01549.
PMID: 39700456
![]() |
![]() |
![]() |